2–3 year olds | 4–8 year olds | 9–17 year olds | ||||
---|---|---|---|---|---|---|
Estimate 95% CI | p Value | Estimate 95% CI | p Value | Estimate 95% CI | p Value | |
Season | ||||||
2012–2013 | 1.00* | 1.00* | 1.00* | |||
2013–2014 | 1.83 (1.69 to 1.97) | 1.14 (1.10 to 1.19) | 1.06 (1.04 to 1.09) | |||
2014–2015 | 1.52 (1.40 to 1.65) | <0.001 | 1.07 (1.04 to 1.12) | <0.001 | 1.03 (1.01 to 1.06) | <0.001 |
Sex | 0.97† | 0.84† | 0.99† | |||
Male | 1.00* | 1.00* | 1.00* | |||
Female | 0.98 (0.92 to 1.04) | 0.48 | 1.01 (0.98 to 1.04) | 0.52 | 1.05 (1.03 to 1.07) | <0.001 |
Region | 0.04† | <0.001† | <0.001† | |||
England/North | 1.03 (0.93 to 1.13) | 1.21 (1.15 to 1.27) | 1.08 (1.04 to 1.11) | |||
England/Midlands | 1.05 (0.95 to 1.16) | 1.13 (1.08 to 1.27) | 1.07 (1.04 to 1.11) | |||
England/South | 1.00* | 1.00* | 1.00* | |||
England/London | 0.83 (0.74 to 0.93) | 0.84 (0.79 to 0.88) | 0.81 (0.78 to 0.85) | |||
Northern Ireland | 1.64 (1.41 to 1.90) | 1.20 (1.12 to 1.29) | 1.46 (1.40 to 1.53) | |||
Scotland | 1.14 (1.03 to 1.26) | 1.15 (1.09 to 1.21) | 1.14 (1.11 to 1.18) | |||
Wales | 0.89 (0.79 to 0.99) | <0.001 | 0.80 (0.75 to 0.85) | <0.001 | 0.88 (0.85 to 0.91) | <0.001 |
High-risk condition | 0.27† | <0.01† | 0.04† | |||
Chronic respiratory disease | 1.00* | 1.00* | 1.00* | |||
Chronic heart disease | 0.86 (0.80 to 0.92) | 0.68 (0.64 to 0.71) | 0.57 (0.54 to 0.59) | |||
Chronic neurological disease | 0.75 (0.67 to 0.85) | 0.69 (0.65 to 0.74) | 0.61 (0.58 to 0.64) | |||
Diabetes | 1.55 (1.17 to 2.00) | 1.78 (1.62 to 1.94) | 1.81 (1.74 to 1.88) | |||
Other high-risk condition‡ | 1.24 (1.08 to 1.40) | <0.001 | 1.16 (1.09 to 1.24) | <0.001 | 1.05 (1.01 to 1.09) | <0.001 |
*Reference group.
†p Value of the interaction term between season and each other predictor.
‡Chronic kidney disease, chronic liver disease, immunosuppression or pregnancy.